Evaluation of the Roche LightCycler parvovirus B19 quantification kit for the diagnosis of parvovirus B19 infections

被引:19
作者
Braham, S [1 ]
Gandhi, J [1 ]
Beard, S [1 ]
Cohen, B [1 ]
机构
[1] Hlth Protect Agcy, Specialist & Reference Microbiol Div, Enter Resp & Neurol Virus Lab, London NW9 5HT, England
关键词
parvovirus B19; real-time PCR; diagnosis;
D O I
10.1016/j.jcv.2003.10.005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: The rapid and quantitative detection of viral DNA is important in the diagnosis of parvovirus B 19 infection in immunocompromised patients and in congenital infection. It is also valuable for monitoring progress following therapeutic interventions. Objectives: To evaluate the diagnostic sensitivity and specificity of the Roche LightCycler (LC) parvovirus B 19 quantification kit in comparison with previously described nested PCR and dot blot hybridisation assays. Study design: Two hundred and twenty eight clinical samples and two standard B19 DNA sera were tested to assess the diagnositic performance of the Roche LC kit. Results: Ten clinical samples (4.3%) gave invalid LC results, including three of five bone marrow samples but only two of 165 serum samples. In the remaining 218 samples, the LC assay detected B 19 DNA in 97.5% (79/81) samples that were positive by the nested PCR. The two samples (from the same patient) that were LC negative were sequenced in a 511-nucleotide region of the NS gene and 42 nucleotide changes were found. The Roche LC assay detected B 19 DNA in 9.5% (13/137) samples that were negative by nested PCR. Analysis of the available clinical and serological data associated with these samples suggested that the LC results in the majority of these cases were true positive. In patients with resolving persistent infection, the LC assay remained positive for longer than nested PCR. Conclusions: The Roche LC assay was more sensitive than the nested PCR used in this study. The additional sensitivity and the quantitative DNA measurements were valuable for monitoring patients with persistent B 19 infection. Practical advantages of the LC assay include a short running time and the possibility to automate the assay. The LC assay provides a controlled and standardised method for quantitative detection of viral DNA for the diagnosis and monitoring of parvovirus B 19 infections but failed to detect a variant strain. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:5 / 10
页数:6
相关论文
共 18 条
[1]   A quantitative, internally controlled real-time PCR Assay for the detection of parvovirus B19 DNA [J].
Aberham, C ;
Pendl, C ;
Gross, P ;
Zerlauth, G ;
Gessner, P .
JOURNAL OF VIROLOGICAL METHODS, 2001, 92 (02) :183-191
[2]  
Azzi Alberta, 1996, Clin Microbiol Infect, V2, P105, DOI 10.1111/j.1469-0691.1996.tb00214.x
[3]   Performance of the Amplicor human immunodeficiency virus type 1 PCR and analysis of specimens with false-negative results [J].
Barlow, KL ;
Tosswill, JHC ;
Parry, JV ;
Clewley, JP .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (11) :2846-2853
[4]   AN AMPLIFIED ELISA FOR THE DETECTION OF PARVOVIRUS-B19 IGM USING MONOCLONAL-ANTIBODY TO FITC [J].
BROWN, KE ;
BUCKLEY, MM ;
COHEN, BJ ;
SAMUEL, D .
JOURNAL OF VIROLOGICAL METHODS, 1989, 26 (02) :189-198
[5]  
Brown Kevin E., 2001, Transfusion (Bethesda), V41, P130, DOI 10.1046/j.1537-2995.2001.41010130.x
[6]  
Clewley Jonathan P., 1993, P367
[7]   POLYMERASE CHAIN-REACTION ASSAY OF PARVOVIRUS B19 DNA IN CLINICAL SPECIMENS [J].
CLEWLEY, JP .
JOURNAL OF CLINICAL MICROBIOLOGY, 1989, 27 (12) :2647-2651
[8]   High-sensitivity PCR detection of pairvovirus B19 in plasma [J].
Daly, P ;
Corcoran, A ;
Mahon, BP ;
Doyle, S .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (06) :1958-1962
[9]   Quantitation of parvovirus B19 DNA sequences by competitive PCR: Differential hybridization of the amplicons and immunoenzymatic detection ion microplate [J].
Gallinella, G ;
Zerbini, M ;
Musiani, M ;
Venturoli, S ;
Gentilomi, G ;
Manaresi, E .
MOLECULAR AND CELLULAR PROBES, 1997, 11 (02) :127-133
[10]   New LightCycler PCR for rapid and sensitive quantification of parvovirus B19 DNA guides therapeutic decision-making in relapsing infections [J].
Harder, TC ;
Hufnagel, M ;
Zahn, K ;
Beutel, K ;
Schmitt, HJ ;
Ullmann, U ;
Rautenberg, P .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (12) :4413-4419